[Mechanism of action and pharmacology of new organometallic compounds active in the treatment of colorectal neoplasms].
Marchetti
P
P
Università degli Studi, L'Aquila. marchetti@rdn.it
Gallà
D A
DA
Cifone
G
G
Ricevuto
E
E
Ficorella
C
C
D000951:Antigens, Neoplasm / Q000378:metabolism; D000970:Antineoplastic Agents / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D017209:Apoptosis; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000235:genetics; D006801:Humans; D009944:Organoplatinum Compounds / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D000077150:Oxaliplatin; D019014:fas Receptor / Q000378:metabolism
D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D019014:fas Receptor; D000077150:Oxaliplatin